“Budget Saving Potential of Pegfilgrastim Biosimilar for the Treatment of Chemotherapy-Induced Febrile Neutropenia, in Italy” (2022) Farmeconomia. Health economics and therapeutic pathways, 23(1). doi:10.7175/fe.v23i1.1516.